Mark Lebwohl. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useHumansPsoriasis/drug therapyPsoriasis/immunologyRecombinant Fusion Proteins/adverse effectsRecombinant Fusion Proteins/therapeutic use
Substances: See more » Antibodies, MonoclonalRecombinant Fusion Proteins
Year: 2002 PMID: 12020234 DOI: 10.1001/archderm.138.5.686
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X